Protocol Review and Monitoring at Roswell Park Cancer Institute (RPCI) is under the directsupervision of Dr Alex Adjei, Associate Director for Clinical Research. Components include the ScientificReview Committee (SRC), the Response Review Committee (RRC), the Clinical Research ManagementSystem (CRMS) and the new Clinical Research Feasibility and Prioritization Committee (CRFPC). The SRCprovides oversight and assures the maintenance of high quality institutional clinical research. All researchstudies conducted at RPCI are reviewed by the SRC prior to submission to the IRB. The scope of the SRCresponsibilities includes review and approval of new and ongoing clinical research studies, review andapproval of study amendments and review and approval of the outcome of the analysis of non-accruing andslow accruing studies. The SRC reviews new studies to ensure that scientific content and study design areappropriate and that statistical oversight and collaboration is in place. The review of non-accruing and slowaccruing studies occurs twice annually. The SRC provides a forum where the utilization of RPCI resourcesand the prioritization of clinical research studies are discussed.The Response Review Committee is charged with monitoring radiological response assessment andreporting the outcome of the review to the Scientific Review Committee and the Data and Safety MonitoringBoard. Ellis Levine, MD, chairs the Response Review Committee and Alan Li twin, MD, provides theradiological review conducted by the Response Review Committee.Under the leadership and supervision of Dr Alex Adjei, Joyce Yasko, PhD oversees the function ofthe SRC including the development of prompt SRC communication of the outcome of the SRC review withthe Principal Investigators and the review of slow or non accruing research studies. Julie Haney BS, CRSDirector, Study Submission and Regulatory Affairs provides the administrative support for the role,responsibilities and outcomes of the SRC. Jennifer Cartonia provides critical secretarial support to theSRC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-32
Application #
7714440
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-28
Project End
2013-04-30
Budget Start
2008-07-28
Budget End
2009-04-30
Support Year
32
Fiscal Year
2008
Total Cost
$76,017
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Rosario, S R; Long, M D; Affronti, H C et al. (2018) Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. Nat Commun 9:5330
Wang, Xue; Niu, Jin; Li, Jun et al. (2018) Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar). Mol Cell Proteomics 17:655-671
Burkard-Mandel, Lauren; O'Neill, Rachel; Colligan, Sean et al. (2018) Tumor-derived thymic stromal lymphopoietin enhances lung metastasis through an alveolar macrophage-dependent mechanism. Oncoimmunology 7:e1419115
Ratajczak, Alexsandra; Feleszko, Wojciech; Smith, Danielle M et al. (2018) How close are we to definitively identifying the respiratory health effects of e-cigarettes? Expert Rev Respir Med 12:549-556
Tsuji, Takemasa; Yoneda, Akira; Matsuzaki, Junko et al. (2018) Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy. Cancer Immunol Res 6:594-604
Narayanan, Sumana; Kawaguchi, Tsutomu; Yan, Li et al. (2018) Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer. Ann Surg Oncol 25:2323-2331
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Terakawa, Tomoaki; Katsuta, Eriko; Yan, Li et al. (2018) High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy. Oncotarget 9:14207-14218
Zhu, Qianqian; Yan, Li; Liu, Qian et al. (2018) Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation. Blood 131:2490-2499
Visioni, Anthony; Kim, Minhyung; Wilfong, Chandler et al. (2018) Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model. J Immunother 41:313-318

Showing the most recent 10 out of 1555 publications